Lessons From the Stroke Prevention Trial in Sickle Cell Anemia (STOP) Study
Open Access
- 1 May 2000
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 15 (5) , 344-349
Abstract
Stroke is generally uncommon in children, but sickle cell disease is associated with a high risk of stroke in the early years of childhood. Large cerebral arteries, especially the middle cerebral and intracranial internal carotid, develop stenosis that predisposes to ischemic stroke. Noninvasive prediction of risk using transcranial Doppler ultrasonography made it possible to test primary stroke prevention in a clinical trial comparing chronic blood transfusion with standard care. A consortium of 14 clinical centers conducted a randomized clinical trial (Stroke Prevention in Sickle Cell Anemia—the "STOP" study) to test a strategy to prevent first stroke in children with sickle cell disease. Over 2000 children were screened with transcranial Doppler ultrasonography and of these, 130 with elevated blood velocity indicating high risk were enrolled in the trial. Regular red cell transfusions sufficient to reduce the percentage of Hb S gene product from over 90 to less than 30 of total hemoglobin was associated with a marked reduction in stroke. The untreated risk of 10% per year was reduced over 90% with treatment, an effect sufficient to cause early termination of the trial. Although treatment was unblinded, the design included blinded adjudication of possible stroke by a panel of neurologists remote from the study sites. The study led to a Clinical Alert, issued by the National Heart, Lung, and Blood Institute, recommending screening and consideration of treatment in children with sickle cell disease and 2 to 16 years of age who are at risk based on transcranial Doppler ultrasonography, and who have not had stroke. (J Child Neurol 2000;15:344-349).Keywords
This publication has 13 references indexed in Scilit:
- Management of Sickle Cell DiseaseNew England Journal of Medicine, 1999
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler UltrasonographyNew England Journal of Medicine, 1998
- Stroke Prevention Trial in Sickle Cell AnemiaControlled Clinical Trials, 1998
- Long‐term stroke risk in children with sickle cell disease screened with transcranial dopplerAnnals of Neurology, 1997
- Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusionsThe Journal of Pediatrics, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Transcranial Doppler correlation with cerebral angiography in sickle cell disease.Stroke, 1992
- The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell DiseaseNew England Journal of Medicine, 1992
- Sickle cell anemia and central nervous system infarction: A neuropathological studyAnnals of Neurology, 1986
- SICKLE CELL ANEMIAA.M.A. American Journal of Diseases of Children, 1923